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In the central nervous system (CNS), dopamine (DA) is involved in motor and cognitive
functions. Although the cerebellum is not been considered an elective dopaminergic
region, studies attributed to it a critical role in dopamine deficit-related neurological and
psychiatric disorders [e.g., Parkinson’s disease (PD) and schizophrenia (SCZ)]. Data on
the cerebellar dopaminergic neuronal system are still lacking. Nevertheless, biochemical
studies detected in the mammalians cerebellum high dopamine levels, while chemical
neuroanatomy studies revealed the presence of midbrain dopaminergic afferents to
the cerebellum as well as wide distribution of the dopaminergic receptor subtypes
(DRD1-DRD5). The present review summarizes the data on the cerebellar dopaminergic
system including its involvement in associative and projective circuits. Furthermore, this
study also briefly discusses the role of the cerebellar dopaminergic system in some
neurologic and psychiatric disorders and suggests its potential involvement as a target
in pharmacologic and non-pharmacologic treatments.
Keywords: cerebellum, dopamine, dopamine receptors, non-traditional large neurons, Parkinson’s disease,
schizophrenia, autism spectrum disorders
INTRODUCTION
In the mammalian cerebellum, the neurotransmitter systems traditionally involved in the synaptic
and extrasynaptic interactions may include the excitatory glutamatergic system (Clements et al.,
1987; Batini et al., 1992; Ottersen, 1993; Zhang and Ottersen, 1993; Batchelor et al., 1994; Grandes
et al., 1994; Nusser and Somogyi, 1997; Knöpfel and Grandes, 2002; Hioki et al., 2003; Sanchez-
Perez et al., 2005; Benagiano et al., 2011; Mugnaini et al., 2011; Uusisaari and De Schutter, 2011;
Mapelli et al., 2015) as well as the inhibitory GABAergic and glycinergic systems (Gabbott et al.,
1986; Wuenschell et al., 1986; Batini et al., 1992; Ottersen, 1993; Wisden et al., 1996; Sastry et al.,
1997; Benagiano et al., 2000a,b; Flace et al., 2004; Crook et al., 2006; Tabata and Kano, 2006;
Uusisaari and De Schutter, 2011; Mapelli et al., 2015), which are both involved in intrinsic and
projective cerebellar circuits (Fredette andMugnaini, 1991; Uusisaari and De Schutter, 2011; Ankri
et al., 2015; Mapelli et al., 2015; Gao et al., 2016). Moreover, in several studies, the existence
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of a cerebellar cholinergic system (Jaarsma et al., 1997; Prestori
et al., 2013; Zhang et al., 2016) and several neuropeptidergic
systems have been demonstrated (King et al., 1992; Joo et al.,
2004; Schibusawa et al., 2008; Benagiano et al., 2009; Ito,
2009). Currently, data on the presence and distribution of
monoaminergic systems in the mammalian cerebellum are still
incomplete and not fully analyzed.
Studies reported in the developmental and adult mammalian
cerebellum the presence of extrinsic monoaminergic pathways.
Studies have been mainly focused on the cerebellar functional
role of serotonin (5-HT) and noradrenaline (NA); as a result,
until now, the functional role of dopamine (DA) in the
cerebellum has been widely disregarded.
In studies using histofluorescence (Hökfelt and Fuxe,
1969) or immunohistochemical methods through specific 5-HT
antiserum, in several mammals, including humans, the presence
of a cerebellar serotonergic fiber system (Takeuchi et al., 1982;
Kerr and Bishop, 1991; Ottersen, 1993; Kitzman and Bishop,
1997; Flace, 2017, 2019a), composed by 5-HT immunoreactive
axonal plexuses of fibers and by neuronal cell bodies and
processes distributed in the cerebellar cortical layers and in the
deep cerebellar nuclei, has been demonstrated (Takeuchi et al.,
1982; Bishop and Ho, 1985; Kerr and Bishop, 1991; Crivellato
et al., 1992; Flace, 2017, 2019a).
The cerebellar serotonergic fibers originate mostly by the
serotonergic cell groups of the reticular formation (B1-B3, B6,
B7, and B9; Dahlström and Fuxe, 1964; Bishop and Ho, 1985;
Törk, 1990, Kerr and Bishop, 1991; Kitzman and Bishop, 1994,
1997). In the cerebellar cortex and the deep cerebellar nuclei,
different serotonergic subtype receptors such as 5-HT1B, 5-HT2A,
5-HT2B, 5-HT3, and 5-HT5A have been demonstrated (Duxon
et al., 1997; Pasqualetti et al., 1998; Sari et al., 1999; Geurts et al.,
2002; Oostland et al., 2013; Marinova et al., 2015). During the
development, a role of 5-HT in dendritic growth and synaptic
plasticity mechanisms has been demonstrated (Bishop et al.,
1988; Oostland and van Hooft, 2013; Oostland et al., 2013).
In the adult cerebellum, 5-HT play a role in the modulation of
the GABAergic and glutamatergic signaling (Strahlendorf et al.,
1991; Cumming-Hood et al., 1993; Kitzman and Bishop, 1997;
Dieudonné and Dumoulin, 2000; Di Mauro et al., 2003; Saitow
et al., 2009; Murano et al., 2011). 5-HT decreases the activity
of the Purkinje neurons (Kerr and Bishop, 1992) by means of
the serotonergic receptor 5-HT1A (Mitoma and Konishi, 1996,
1999). 5-HT may set PCs at a preferred firing rate by modulation
of transient outward h currents (Strahlendorf et al., 1984; Wang
et al., 1992).
5-HT is involved in the long-term cerebellar effects, as the
modulation of postsynaptic induction of long term depression
(LTD), mainly by means of the serotonergic receptors 5-HT2A
and 5-HT2B, which have been expressed on the Purkinje neurons
(Maeshima et al., 1998; Cornea-Hébert et al., 1999).
In addition, these serotonergic receptor subtypes activate
phospholipase C, resulting in the production of inositol-
3 trisphosphate (IP3), which can regulate the threshold of
regenerative cycles of Ca2+ elevation (Raymond et al., 2001). In
chemical neuroanatomy studies, the presence of noradrenergic
innervation in the cerebellum of rodents and primates (including
humans; Hökfelt and Fuxe, 1969; Siggins et al., 1971; Landis
and Bloom, 1975; Yamamoto et al., 1977; Pasquier et al., 1980;
Hayashi, 1987; Pompeiano et al., 1989; Powers et al., 1989; Yew
et al., 1995; Rosin et al., 1996; Talley et al., 1996; Gould et al.,
1997; Melchitzky and Lewis, 2000) by means of fluorescent
histochemistry (Falck and Torp, 1962; Hökfelt and Fuxe, 1969),
or by specific antisera for dopamine β hydroxylase (DBH), the
NA biosynthesizing enzymes has been demonstrated (Fritschy
and Grzanna, 1989). Cerebellar noradrenergic fibers mainly
originate from the noradrenergic cell groups of the reticular
formation (A4-A7; Dahlström and Fuxe, 1964; Hökfelt and Fuxe,
1969; Pickel et al., 1973; Pasquier et al., 1980; Dietrichs, 1988;
Powers et al., 1989). Such noradrenergic fibers are localized in the
three cerebellar cortical layers and in the deep cerebellar nuclei,
oriented so as to generate axonal plexuses (Sachs et al., 1973;
Pasquier et al., 1980; Dietrichs, 1985; Felten et al., 1986; Powers
et al., 1989; Melchitzky and Lewis, 2000).
In the human developmental cerebellum, at 16–18 and 26–
28 weeks, a transient expression of noradrenergic neuronal cell
bodies and processes occurs in the cerebellar cortex and in
the deep cerebellar nuclei has been demonstrated (Yew et al.,
1995). In addition, in the cerebellum of mammals, extensive
distribution of the β2 adrenergic subtype receptor (Pompeiano
et al., 1989; Voogd et al., 1996) and, to a lesser extent, of β1,
α1, and α2 adrenergic subtype receptors have been demonstrated
(Pompeiano et al., 1989; McCune et al., 1993; Rosin et al., 1996;
Talley et al., 1996; Voogd et al., 1996). In the development,
it has been found that the cerebellar noradrenergic system
influences mainly the GABAergic synaptogenesis (Sievers et al.,
1981; Sievers and Klemm, 1982; O’Leary and Leslie, 2003; Happe
et al., 2004; Hirono et al., 2014). In the adult cerebellum, NA
plays a pivotal role in the modulation of the glutamatergic and
GABAergic synaptic signaling (Moises et al., 1983; Woodward
et al., 1991; Hirono and Obata, 2006; Hirono et al., 2014;
Lippiello et al., 2015). Noradrenaline exerts on the Purkinje
neurons two types of influence. An increase of the intracellular
levels of cAMP protein kinase-dependent by means on the beta-
adrenergic receptor (Kano et al., 1992; Cheun and Yeh, 1996);
the levels of cAMP can, in turn, enhance a form of neuronal
plasticity called rebound potentiation (RP; Kano et al., 1992;
Cheun and Yeh, 1996; Kawaguchi and Hirano, 2002). Moreover,
NA influences in the Purkinje neurons the expression of the
immediate-early genes, c-fos and Jun-B (Pompeiano, 1998). The
induction of immediate-early genes in the Purkinje neurons
appears to play a role in the long-term biochemical changes
involved in the maintenance of cerebellar long-term plasticity
such as LTD (Pompeiano, 1998).
On the other hand, currently, the presence and the
distribution of a dopaminergic system in the cerebellum and
its functional role is controversial or neglected (Oertel, 1993;
Ottersen, 1993; Kwong et al., 2000). However, several studies
demonstrated the involvement of the cerebellum in DA related
neurological and psychiatric disorders, such as Parkinson’s
disease (PD), schizophrenia (SCZ), autism spectrum disorders
(ASD), and drug addiction (Glaser et al., 2006; Andreasen
and Pierson, 2008; Mittleman et al., 2008; O’Hallaran et al.,
2012; Lewis et al., 2013; Wu and Hallett, 2013; Parker et al.,
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2014, Carta et al., 2019; Gil-Miravet et al., 2019; Miquel
et al., 2020). Therefore, the goal of the present review
is to provide a comprehensive overview of the presence,
distribution, and functional role of the cerebellar dopaminergic
system, also discussing its potential pathophysiological and
clinical implications in some neurological and psychiatric DA-
related disorders.
MORPHOLOGICAL ASPECTS OF THE
DOPAMINERGIC CEREBELLAR SYSTEM
Although the presence of a dopaminergic system in the
cerebellum is in part predictable, currently, the cerebellum is
not strictly considered a dopaminergic area (Glowinski and
Iversen, 1966; Lindvall and Björklund, 1974; Beckstead et al.,
1979; Ottersen, 1993; Masilamoni et al., 2010). In biochemical
studies, high levels of DA in the human postmortem cerebellum
(Adolfsson et al., 1979; Roubein and Embree, 1979; Spokes, 1979;
Gottfries, 1980) and in the rat and monkey cerebellum were
detected (Versteeg et al., 1976; Mefford et al., 1982; Glaser et al.,
2006; Quansah et al., 2018). Furthermore, in the mammalian
cerebellum, in vivo studies by means of positron emission
tomography (PET) revealed a significant presence of selective
dopamine transporter ligands (DAT-Ls) (Schoeps et al., 1993;
Lundkvist et al., 1995; Hall et al., 1999; Emond et al., 2008;
Varrone et al., 2009; Jiang et al., 2019).
Chemical neuroanatomy studies on the detection of
dopaminergic neuronal elements in the cerebellum of mammals
(including human) makes use of direct antisera against DA
and of [3H]-dopaminergic ligands (Panagopoulos et al., 1991;
Panagopoulos and Matsokis, 1994) or antisera against the
specific dopaminergic marker, the dopamine transporter (DAT),
the plasma membrane monoamine transporter involved in DA
synaptic reuptake (Table 1; Melchitzky and Lewis, 2000; Dunnet
et al., 2005; Giompres and Delis, 2005; Delis et al., 2008; Kim
et al., 2009; Flace et al., 2019b, 2020), the indirect marker of the
dopaminergic neurotransmission, the dopamine and adenosine
3′-5′-monophosphate (cAMP)-regulated protein Mr 32,0000
(DARPP-32), a protein phosphatase-1 inhibitor involved in
dopaminergic neuronal synaptic signaling (Table 1; Alder and
Barbas, 1995; López et al., 2010; Nishi and Shuto, 2017), or,
indirectly, by means of antisera against not elective markers
for DA, such as tyrosine hydroxylase (TH), the rate-limiting
enzyme DA biosynthesis, which catalyzes the conversion of
L-tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA) (Table 1;
Ikai et al., 1992; Fujii et al., 1994; Melchitzky and Lewis, 2000;
White and Thomas, 2012) and vesicular monoamine transporter
2 (VMAT2), the synaptic vesicles transporter of monoamine
neurotransmitters such as DA, NA, 5-HT, and histamine (HIS)
(Table 1; Kim et al., 2009; Lawal and Krantz, 2013).
During the development of the mouse cerebellar cortex, a
transient expression of TH in Purkinje neurons in different ages
from postnatal day 3 (P3) to 11 months (M11) has been observed
(Fujii et al., 1994). The TH expression appears in the Purkinje
neurons at P8 in the cerebellar vermis, increases at P13–P15,
reduces at P19, and then increases again after 1 month of age,
reaching a maximum expression at 11 months (Fujii et al., 1994).
In the adult mouse cerebellum, the TH immunoreactive fibers
are in the vermal lobules V and VI, whereas the lowest numbers
are located in lobule X, and in each deep cerebellar nuclei, a
dense plexus of TH immunoreactive varicose fibers has been
mainly detected (Table 1; Nelson et al., 1997). Whereas, TH
immunoreactive cell bodies of Purkinje neurons have been found
in the flocculus, paraflocculus, vermal lobules VI–X, and in
the hemispheric lobules IX–X (Table 1; Nelson et al., 1997). In
pharmacological studies, in the mouse cerebellum DA specific
binding sites of [3H]DA and [3H]spiperone has been detected
(Panagopoulos and Matsokis, 1994).
Moreover, in the adult mouse cerebellum, specific binding
of the DA uptake inhibitor 3[H]GBR12935 in the paraflocculus,
lobules IV, VI, IX, X, and lobule simplex Crus I and II has
been detected (Delis et al., 2008). In the cerebellar cortex,
the specific binding of 3[H]GBR12935 was mainly distributed
in the molecular layer and in the granular layer, while DAT
immunoreactivity has been mainly detected in the cell bodies
of the Purkinje neurons and in some neuron types of the deep
cerebellar nuclei (Table 1; Delis et al., 2008). Furthermore, in the
mouse cerebellum, DARPP-32 immunoreactive Purkinje neuron
cell bodies in the laminae of all lobules have been observed
(Table 1; Alder and Barbas, 1995).
In the rat cerebellum, the DA immunoreactivity presents a
uniform distribution pattern in all lobules, and in the layers
of the cerebellar cortex the DA immunoreactivity was mainly
detected in the molecular layer in climbing fiber-like forms, while
a small number of DA immunoreactive fibers within the Purkinje
neuron layer and in the granular layer were found (Table 1;
Panagopoulos et al., 1991).
Furthermore, in the rat cerebellum, the TH immunoreactive
fibers in the paraflocculus and crus I and II ansiform lobules
have been mainly detected (Table 1; Ikai et al., 1992); whereas, a
high number of VMAT2 immunoreactive ‘puncta’ (attributable to
axon terminals or short sections of dendrites) has been observed
in the lobule IX of the posterior cerebellum (Table 1; Kim et al.,
2009).
In the rat cerebellar cortex, a low number TH immunoreactive
fibers variously oriented in the Purkinje neuron layer and in the
granular layer has been detected; instead, in the molecular layer,
a high number of climbing-like oriented TH immunoreactive
fibers has been observed (Table 1; Takada et al., 1993), and
VMAT2 small immunoreactive “puncta” were observed between
the Purkinje neuron cell bodies and in the molecular layer in
close relationship with the dendritic arborizations of the Purkinje
neurons (Table 1; Kim et al., 2009).
Biochemical analysis revealed significant levels of DA in the
deep cerebellar nuclei of rat, with the highest DA levels being
localized in the fastigial and dentate nuclei (Glaser et al., 2006),
which is in line with a morphological study that revealed the
presence of DAT immunoreactive fibers in all deep cerebellar
nuclei (Delis et al., 2008). Moreover, a wide distribution of DAT
immunoreactive fibers in the three layers of the cerebellar cortex
and in the deep cerebellar nuclei has been revealed (Delis et al.,
2008).
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TABLE 1 | Distribution of the catecholaminergic and dopaminergic markers in the mammalian cerebellum.
Catecholaminergic and
dopaminergic marker








- Fibers in the neuropil







- Fibers in the neuropil
- Mossy
fiber rosettes-like
- Fibers in the neuropil
of all nuclei
Lobules I, III, V, VI, VIII,
IX, X, Crus I, Crus II,
paraflocculus
Vesicular Monoamine








– – Lobule IX B
Dopamine Transporter (DAT)
(dopaminergic marker)
- Fibers in the neuropil
- Dendrites of
Purkinje neurons
- Purkinje neurons cell
bodies and
processes
- Fibers in the neuropil
- Fibers randomly
distributed
- Clusters in the sites
of glomeruli complex
- Granules cell bodies
(occasionally)





- Fibers and puncta
(axon terminals)

















– – All lobules
In addition, DARPP-32 immunoreactive dendritic
arborization of the Purkinje neurons in the molecular layer
of all cerebellar lobules has been observed (Table 1; Alder and
Barbas, 1995).
In the rat cerebellar cortex, the presence of TH
immunoreactive cell bodies of Purkinje neurons has been
demonstrated in the lobules I and X of the vermis, in the
paraflocculus, and in crus I and II ansiform lobules (Table 1;
Takada et al., 1993) Instead, Kim et al. (2009) evidenced the
presence of TH immunoreactive cell bodies of Purkinje neurons
predominantly in the lobules VIII–X and a discontinuous
presence in the lobules VI and VII, whereas a high number of
DAT immunoreactive cell bodies of Purkinje neurons has been
detected in the lobule IX of the posterior cerebellum (Table 1;
Kim et al., 2009).
In the opossum cerebellum, most of TH immunoreactive
fibers have been found in the lobules III-VIII of the vermis
and, to a lesser extent, in lobules I and X (Table 1; Nelson
et al., 1997). Moreover, in the opossum cerebellar cortex,
the TH immunoreactive fibers were mainly localized in
the Purkinje neurons layer; they surround the cell bodies
of the Purkinje neurons or run parallel to the plane of
the Purkinje neuron layer, whereas, in the molecular layer,
only a small amount was detected (Table 1; Nelson et al.,
1997), and in the granular layer, the TH immunoreactive
fibers featured a random distribution (Nelson et al.,
1997).
In addition, a moderate number of randomly distributed TH
immunoreactive fibers has been detected in the deep cerebellar
nuclei (Nelson et al., 1997).
In the cat cerebellum, the highest density of TH
immunoreactive fibers were distributed in the vermal lobules
V and VI and in the hemispheric lobules VI and crus I and II;
meanwhile, the lowest density of fibers has been observed in
lobules I–III and VIII–X (Table 1; Nelson et al., 1997). In the cat
cerebellar cortex, the high density of TH immunoreactive fibers
have been observed in the granular layer, where they present a
random orientation, and in the Purkinje neurons layer, where
they surround the cell bodies of the Purkinje neurons have been
observed. Instead, in the molecular layer, only a few densities
of TH immunoreactive fibers with a perpendicular orientation
that often extend radially to the surface of the pial surface of the
cortex have been detected (Table 1; Nelson et al., 1997). Finally,
a moderate density of TH immunoreactive varicose fibers in the
deep cerebellar nuclei have been also found (Table 1; Nelson
et al., 1997).
In the monkey cerebellum, we found a low density of TH
immunoreactive fibers to be distributed in the lobules of the
vermis and of both cerebellar hemispheres, whereas the DAT
immunoreactive fibers were only observed in the vermis of the
following lobules II, III, IV, VIIIA, VIIIB, IX, and X (Table 1;
Melchitzky and Lewis, 2000).
In the monkey cerebellar cortex, a low density of TH
immunoreactive fibers in the granular layer and in the molecular
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FIGURE 1 | Dopamine transporter (DAT) immunoreactivity in the cerebellar
cortex. The DAT immunoreactivity is detectable in neuronal bodies and
processes of all the layers of the cerebellar cortex. In the molecular layer, DAT
immunoreactivity in basket neurons (arrowheads); primary and secondary
trunks dendritic and apical dendrites of Purkinje neurons; immunonegative
stellate neurons, fine clusters of DAT immunoreactivity in the neuropil of the
layer. In the Purkinje neuron layer, DAT immunoreactive Purkinje neuron cell
body (single asterisk), DAT immunonegative Purkinje neuron (double asterisk).
In the granular layer, DAT immunoreactivity in space of Held, DAT
immunoreactivity in the cell body, and axon-like processes of the synarmotic
neuron (arrow). (Scale bar: 25µm).
layer, has been detected while a higher density of TH plexuses
and axonal terminals just beneath the Purkinje neuron cell bodies
has been found. Conversely, DAT immunoreactive fibers to be
randomly distributed in the granular layer; however, we also
found forming plexuses around the deep pole of the cell bodies
of the immunonegative Purkinje neurons has been observed. In
contrast, in the molecular layer, no DAT immunoreactive fibers
have been detected (Table 1; Melchitzky and Lewis, 2000).
Currently, in the monkey cerebellum studies, there is no
evidence that proves the existence of dopaminergic neurons.
Despite this, a biochemical study demonstrated significant levels
of DA in all deep cerebellar nuclei, and the highest levels have
been detected in the interpositus and dentate nuclei, (Glaser
et al., 2006). Furthermore, in all cerebellar lobules of the monkey
cerebellar cortex, a wide presence of DARPP-32 immunoreactive
cell bodies and dendritic arborizations of Purkinje neurons has
been detected (Table 1; Alder and Barbas, 1995).
In the human cerebellum, immunohistochemical experiments
revealed the presence of DAT immunoreactive fibers and
neuronal cell bodies in lobules VII and IX (crus I and II,
ansiform lobules, and tonsilla) and in the dentate nucleus
(Table 1; Figures 1, 2; Flace, 2017, 2019b, 2020; Flace et al.,
2018a, 2019b, 2020). There is a significant presence of DAT
immunoreactive dendritic arborization of the Purkinje neurons
in the molecular layer of the human cerebellar cortex (Table 1;
Figure 1). Moreover, the DAT immunoreactivity has been
detected in form of clusters in the neuropil among the space
FIGURE 2 | Dopamine receptor type 2 (DRD2) immunoreactivity is observable
in neuronal bodies and processes in the layers of the cerebellar cortex. In the
ML:DRD2 immunoreactive basket and stellate neuron cell bodies (arrows),
DRD2 immunoreactive primary, secondary, and apical dendrites of Purkinje
neurons, DRD2 immunoreactive Purkinje neuron cell bodies (single asterisk). In
the granular layer, DRD2 immunoreactivity in space of Held; DRD2
immunoreactive Golgi neuron cell body (arrow) (Scale bar: 20µm).
FIGURE 3 | Dopamine transporter (DAT) immunoreactivity in the dentate
nucleus. The dopamine transporter (DAT) immunoreactivity is detectable in the
dentate nucleus gray substance and in the neighboring white substance. DAT
immunoreactive small neuron cell bodies (arrowheads); DAT immunonegative
small neuron cell body (single asterisks) DAT immunoreactive cell body of
projective neuron type, central neuron (arrow); fine clusters of DAT
immunoreactivity in the neuropil of the nucleus and in the neighboring withe
substance (Scale bar: 15µm).
of Held, the sites of the cerebellar glomeruli (Table 1; Figure 1;
Flace, 2017, 2019b, 2020; Flace et al., 2018a, 2019b, 2020).
In addition, the DAT immunoreactivity in the cell bodies
of Purkinje neurons and of synarmotic neurons (Neuron of
Landau) has been also detected (Table 1; Figure 1). This latter,
one of the non-traditional large neuron granular layers was
involved in corticocerebellar and in corticonuclear projective
circuits (Flace et al., 2004, 2018a, 2019b, 2020; Ambrosi et al.,
2007; Flace, 2017, 2019a,b, 2020). The DAT immunoreactivity
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TABLE 2 | Distribution of the dopaminergic receptor subtypes in the mammalian cerebellum.
Dopamine receptor
subtypes
Molecular layer Purkinje neuron layer Granular layer Deep cerebellar nuclei
Dopamine Receptor D1
(DRD1)
- Stellate and Basket neuronal cell
bodies and processes
- Dendrites of the Purkinje neurons




– - Projective and associative





- Stellate and Basket neuronal cell
bodies and processes
- Dendrites of the Purkinje neurons




- Clusters in the neuropil in
the glomeruli complex
sites
- In cell bodies
and processes:






- Fibers and puncta (axon
terminals)
- Projective and associative





- Stellate and Basket neuronal cell
bodies and processes
- Dendrites of the Purkinje neurons







– – Clusters in the neuropil in




- Stellate and Basket neuronal cell
bodies and processes
- Dendrites of the Purkinje neurons





in the cell bodies of few granules has been also detected (Flace
et al., 2019a,b, 2020). Moreover, DAT immunoreactive nerve
fibers variously oriented in the subcortical white substance, has
been detected (Figure 1; Flace et al., 2019a,b, 2020). In the dentate
nucleus, the DAT immunoreactivity in neuronal cell bodies and
processes of different neuron types has been detected (Table 1;
Figure 3); the small neuron type is involved in intrinsic circuits,
the medium neuron type (Table 1; Figure 3) mainly involved
in intrinsic and also in extrinsic circuits, and four different
large neuron types, which include the central neuron, the
border neuron, the intermediate asymmetrical neuron, and the
intermediate fusiform neuron, involved in projective circuits of
the dentate nucleus (data not showed; Chan-Palay, 1977; Maric,
2010; Ristanović et al., 2010; Flace et al., 2017, 2019b, 2020; Flace,
2018). Dopamine transporter immunoreactivity in neuronal cell
bodies and processes of the perivascular neuron type has also
been observed, a neuron type may be involved in regulatory
mechanisms of blood–brain barrier (BBB) permeability and in
volume transmission mechanisms (data not showed; Flace et al.,
2004; Ambrosi et al., 2007; Flace, 2017, 2018, 2019b, 2020).
Furthermore, through different methods in the cerebellum
of mammals, a wide distribution of the dopaminergic receptor
subtypes (DRD1-DRD5) has been observed (Table 2; Camps
et al., 1989; Cortés et al., 1989; Levant, 1998; Barili et al., 2000;
Kiss et al., 2011; Flace et al., 2019b, 2020). A broad expression of
all the dopaminergic receptor subtypes (DRD1-DRD5) has been
demonstrated in the rodent and human cerebellum (Table 2;
Martres et al., 1985; Camps et al., 1990; Mengod et al., 1992;
Panagopoulos and Matsokis, 1994; Ricci et al., 1995a,b, 1996;
Vessotskie et al., 1997; Levant, 1998; Barili et al., 2000; Khan
et al., 2000; Hurley et al., 2003; Delis et al., 2004; Kim et al.,
2009; Flace, 2017, 2018, 2019b; Flace et al., 2018a, 2019a,b,
2020).
In the three layers of the cerebellar cortex, the dopaminergic
receptor subtypes present a different distribution pattern. In the
molecular layer, immunoreactivity to DRD2, DRD3, and DRD5
receptors in the cell bodies and processes of stellate neurons,
basket neurons, and in the dendritic arborizations of the Purkinje
neurons has been detected (Table 2; Figure 2). Moreover, in
the neuropil of the molecular layer, fine clusters of DRD2
immunoreactivity were detected (Table 2; Figure 2; Camps et al.,
1990; Ricci et al., 1995b, 1996; Khan et al., 1998; Levant, 1998;
Barili et al., 2000; Flace et al., 2018a, 2019a,b, 2020).
In the Purkinje neuron layer, DRD1, DRD2, DRD3, and
DRD5 immunoreactive cell bodies of Purkinje neurons have been
observed (Table 2; Figure 2; Camps et al., 1990; Bouthenet et al.,
1991; Ricci et al., 1995a,b; Khan et al., 1998; Lazarov et al.,
1998; Barili et al., 2000; Kim et al., 2009; Flace et al., 2018a,
2019a,b, 2020). In the granular layer, DRD2 immunoreactivity
in the cell bodies and processes of granules, Golgi neurons
(Table 2; Figure 2), and in different non-traditional large neuron
types of the granular layer distributed in three zones has been
detected (Flace et al., 2004; Flace, 2017, 2019b, 2020) such
as the Lugaro neuron, candelabrum neuron, and perivascular
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neuron in the external zone of the layer, the triangular neuron
in the intermediate zone, the ellipsoidal neuron, and the globular
neuron in the internal zone has been detected (Table 2; data
not showed; Flace et al., 2004; Ambrosi et al., 2007; Flace,
2017, 2019b, 2020). In addition, DRD1, DRD2, and DRD4
immunoreactive clusters in the neuropil of the granular layer
have been found (Table 2; Figure 2), and DRD2 and DRD5
immunoreactivity in cell bodies of granules has been observed
(Table 2; data not showed; Camps et al., 1990; Brouwer et al.,
1992; Ricci et al., 1995a,b; Khan et al., 1998; Lazarov et al., 1998;
Barili et al., 2000; Kim et al., 2009; Flace, 2017, 2019b; Flace
et al., 2018a, 2019b, 2020). Furthermore, among immunonegative
granules, the DRD2 immunoreactivity in form of clusters in the
space of Held, the sites of the cerebellar glomeruli complex has
been detected (Table 2; Figure 2; Flace et al., 2018a, 2019a,b,
2020).
In the mouse and human dentate nucleus, the presence of
DRD1 and DRD2 immunoreactive cell bodies and processes
of different large projective neuron types and small associative
neuron types has been demonstrated (Table 2; Figure 4); the
DRD2 immunoreactivity has also been observed in form of fine
clusters in the neuropil of the dentate nucleus (Table 2; Figure 4;
Flace, 2017; Flace et al., 2018a, 2019a,b, 2020; Locke et al., 2018).
In chemical neuroanatomy studies carried out on the
cerebellum by means of antisera directed against the TH, the
rate-limiting enzyme of DA biosynthesis and the presence of
numerous TH immunoreactive fibers in the various lobules
and laminae of the cerebellar cortex as well as in the deep
cerebellar nuclei have been demonstrated (Austin et al., 1992;
Ikai et al., 1992; Takada et al., 1993, Nelson et al., 1997).
In addition, regarding the TH immunoreactivity, it should be
indicated that it is related to the presence of NA or DA, or
both, since by carrying out a selective depletion of NA, most
of the immunoreactivity is abolished (Fuxe, 1965; Hökfelt and
Fuxe, 1969; Bloom et al., 1971). Moreover, using biochemical
techniques, low levels of DA were found in the cerebellum
(Carlsson, 1959; Glowinski and Iversen, 1966; Landis and
Bloom, 1975). In addition, using antisera against DBH, the
enzyme responsible for the biosynthesis of NA, highlights the
presence of fibers in the cerebellum, which presented only partial
similarity to those observed in studies using directed antisera
against DA (Verney et al., 1988; Panagopoulos et al., 1991).
Furthermore, more recent studies in the cerebellum of various
mammals species and in other regions of the central nervous
system (CNS), demonstrated which distribution patterns of TH
immuroreactivity were mainly correlated to catecholaminergic
and not electively to the dopaminergic neurotransmission but
did not exclude it; (Fallon and Moore, 1978; Hökfelt et al.,
1984; Asan, 1993; Takada et al., 1993; Nelson et al., 1997).
On the contrary, studies that electively used antisera against
DAT evaluate specifically the distribution patterns related to
dopaminergic neurotransmission (Melchitzky and Lewis, 2000;
Delis et al., 2008; Flace et al., 2018a, 2019b, 2020). In addition,
the DAT immunohistochemial studies evidenced the presence of
a specific subpopulation of dopaminergic neuronal cell bodies
and processes in the cerebellum (Melchitzky and Lewis, 2000;
Delis et al., 2008; Flace et al., 2018a, 2019b, 2020), which is in
FIGURE 4 | Dopamine receptor type 2 (DRD2) immunoreactivity in the dentate
nucleus. The (DRD2) immunoreactivity is detectable in the dentate nucleus
gray substance and in the neighboring withe substance; DRD2
immunoreactive small neuron cell bodies (arrowheads); DRD2 immunoreactive
cell body of projective neuron type, central neuron (arrow); diffuse DAT
immunoreactivity in the neuropil of the nucleus (Scale bar: 15µm).
agreement with the studies on the distribution pattern of the
dopaminergic receptors subtype in the cerebellar neuronal cell
bodies and processes (Martres et al., 1985; Camps et al., 1990;
Mengod et al., 1992; Ricci et al., 1996; Vessotskie et al., 1997;
Levant, 1998; Barili et al., 2000; Khan et al., 2000; Delis et al., 2004;
Kim et al., 2009; Flace et al., 2018a, 2019a,b, 2020).
In fact, the relationship of these data suggest the existence
in the cerebellum of detailed dopaminergic neurotransmitter
mechanisms. For example, in terms of the distribution pattern
of the DAT immunoreactivity (Melchitzky and Lewis, 2000;
Delis et al., 2008; Flace et al., 2018a, 2019b, 2020) and
of the dopaminergic D1-like and D2-like subtype receptors
immunoreactivity (Camps et al., 1990; Bouthenet et al., 1991;
Ricci et al., 1995a,b; Khan et al., 1998; Lazarov et al., 1998;
Barili et al., 2000; Kim et al., 2009; Flace et al., 2018a,
2019a,b, 2020), both were expressed in the Purkinje neurons
cell bodies, dendritic arborizations, and axons, and this suggests
the existence of a detailed cerebellar modulation by means of
dopaminergic neurotransmission mechanisms in intrinsic and
extrinsic cerebellar circuits.
PHYSIOLOGICAL ASPECTS ON THE
DOPAMINERGIC CEREBELLAR SYSTEM
In animal model studies, it has been indirectly demonstrated an
active role of DA in the cerebellum; indeed, the administration
of lacosamide and morphine in a hypoglycemic animal model
decreased the cerebellar level of dopamine significantly (Guzman
et al., 2014). In the cerebellum of albino rats, the long
administration of morphine sulfate determines a decrease in
the levels of DA and histopathological changes (Bekheet et al.,
2010). Hypoxic conditions induced in the cerebellum of neonatal
rats a decrease in the DA levels and a reduced expression of
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the dopaminergic subtype receptors DRD1 and DRD2; these
decreases are in part reversed by the supplementation of glucose,
oxygen, and adrenaline (Joseph et al., 2010). Moreover, in the
cerebellum of rodents, high levels of DA have been involved
in neuronal synaptic mechanisms characterized by DA release
and uptake (Efthimiopoulos et al., 1991; Dethy et al., 1997). In
addition, inmouse cerebellar slices, the presence of a high-affinity
Na+-dependent DA uptake system has been demonstrated, and
this has been characterized by a K+-induced, Ca+2-dependent
dopamine release mechanism (Efthimiopoulos et al., 1991).
Moreover, in several studies, it has been demonstrated in
striatal medium spiny neurons a direct influence of DA in the
mechanism of structural plasticity of dendritic spines (Yagishita
et al., 2014). In the rat cerebellum, DA may influence in
the Purkinje neurons the induction of RP a form of long-
lasting synaptic plasticity at inhibitory synapses by means
of the cAMP-regulated protein DARPP-32 highly expressed
in Purkinje neurons and involved in dopaminergic neuronal
synaptic signaling (Alder and Barbas, 1995; Kawaguchi and
Hirano, 2002).
Moreover, in rat Purkinje neurons dendrites, a release of
DA from vesicular extrasynaptic and postsynaptic sites resulted
in dopaminergic receptors paracrine and autocrine activation
(volume transmission), which produced a Depolarization-
Induced Slow Current (DISC; Kim et al., 2009). Moreover, in
pharmacological experiments a close functional relationship in
dopaminergic Purkinje neurons between DA signaling and DISC
has been demonstrated; in fact, it was blocked by dopaminergic
receptor antagonist (e.g., clozapine, haloperidol, and eticlopride),
VMAT2 inhibitors (reserpine and tetrabenazine), and dopamine
reuptake inhibitors (e.g., rimcazole; Kim et al., 2009).
Furthermore, it has been suggested in recent studies which TH
immunoreactive Purkinje neurons and DRD1 immunoreactive
large projective neuron types of the dentate nucleus may be
involved in the modulation of cerebellar cognitive functions
(Locke et al., 2018, 2020). The selective chemogenetic inhibition
of the DRD1 immunoreactive neuron type of the dentate nucleus
could be involved in the impairment of cognitive functions such
as spatial navigation memory, working memory, and pre-pulse
inhibition of the acoustic startle reflex (Locke et al., 2018). In
mice, a selective reduction of TH immunoreactive cerebellar
Purkinje neurons has been correlated to a specific impairment
of cognitive functions, such as behavioral flexibility, response
inhibition, social recognition memory (Locke et al., 2020).
From the analysis of these experimental physiological
and pharmacological studies, a potential role of the
neuronal dopaminergic system at the cerebellar level
emerges, especially in the synaptic and extrasynaptic
neurotransmission and neuromodulation mechanisms
(Efthimiopoulos et al., 1991; Dethy et al., 1997; Kawaguchi
and Hirano, 2002; Kim et al., 2009) and, in cognitive
functions related to the cerebellar activity (Locke et al.,
2018, 2020). Overall, they deserve further evaluation in order
to better understand the relevance of the morphofunctional
role played by the dopaminergic innervation in the




In rodents, lesional and axonal tracing studies has been
demonstrated that the cerebellar extrinsic dopaminergic fibers
originate from the midbrain dopaminergic cell groups (A8-A10),
which mainly consist of the ventral tegmental area (VTA) (A10)
and to lesser extent by the retrorubral nucleus (A8) and the
pars compacta of the substantia nigra (SNpc) (A9; Dahlström
and Fuxe, 1964; Kizer et al., 1976; Chan-Palay, 1977; Oades and
Halliday, 1987; Ikai et al., 1992; Melchitzky and Lewis, 2000; Kim
et al., 2009).
In addition, in cat and in rat, a direct cerebellar influence
on the midbrain dopaminergic nuclei (A8-A10) has been
demonstrated. Fibers from the vermian cerebellar cortex and
from the fastigial nucleus reach the ipsilateral VTA, whilst fibers
from the interpositus and dentate nuclei reach the contralateral
dorsal VTA and the medial and dorsal SNpc; moreover, 20% of
the fibers had bilateral interconnections (Figure 9; Snider and
Maiti, 1976).
In the rat cerebellum, using horseradish peroxidase (HRP)
anterograde and retrograde transport methods, the efferents of
the dentate and interpositus nuclei to the contralateral midbrain
dopaminergic cell groups A8-A10 have been demonstrated
(Figure 9; Perciavalle et al., 2013).
Electrical stimulation of cat cerebellar dentate nucleus
influenced the dopaminergic activity of the ipsilateral SNpc,
which in turn increased the release of [3H]-DA in the
contralateral caudate nucleus and decreasing such release in the
ipsilateral caudate nucleus. Moreover, the electrical stimulation
of the fastigial nucleus increased only the release of [3H]-DA
in the ipsilateral caudate nucleus (Nieoullon et al., 1978), and
the electrical stimulation of the posterior interpositus nucleus
increased the release of [3H]-DA in ipsilateral SNpc and in the
contralateral caudate nucleus while decreasing the release [3H]-
DA in the ipsilateral caudate nucleus (Nieoullon and Dusticier,
1980). In addition, the electrical stimulation of the mouse
cerebellar dentate nucleus was elicited mainly in the contralateral
nucleus accumbens (NAc), determining an asymmetrical and
lateralized DA release (Figure 9; Holloway et al., 2019).
Moreover, in the last decades, the developments in
neuroscience research of non-invasive and in vivo diffusion
Magnetic Resonance Imaging and tractography have been
increasingly used for the neuroanatomical reconstruction of
putative white substance tracts or links of the human brain
(Jeurissen et al., 2014; Cacciola et al., 2016a,b, 2017a,b, 2019).
Although relatively few studies focused on the connectivity of
midbrain nuclei, some of these reported structural connectivities
between dopaminergic midbrain regions and the cerebellum
(Bareš et al., 2015; Milardi et al., 2016; Cacciola et al., 2017a;
Flace et al., 2017, 2018a,b, 2019a, 2020). An early work based on
diffusion tensor imaging (DTI) and deterministic tractography
aimed at the reconstruction of the median forebrain bundle
(MFB), which represents the main white substance pathway
connecting VTA and SNpc to the prefrontal cortex (PFC), found
also a descending branch reaching to the cerebellum and in
particular to the dentate nucleus through the superior cerebellar
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FIGURE 5 | Structural connectivity of SNpc and VTA, including putative midbrain-cerebellar connectivity. Data were obtained from the 100-unrelated-subjects sample
of the HCP repository (see Van Essen et al., 2013) Diffusion datasets were processed using a multi-shell, multi-tissue constrained spherical deconvolution
(MSMT-CSD) algorithm (see Jeurissen et al., 2014). A number of 10,000 streamlines passing through the left SNpc (dark red) and VTA (light red) regions of interest
(see Pauli et al., 2018) (A) was generated. Streamlines were mapped to structural scans, transformed to MNI152 standard space, binarized, and summed up to
obtain tract maximum probability maps (MPMs). A threshold of 50% was applied to show only tracts overlapping in at least half of the sample (B). Tractography was
run on 30 high-quality 3T structural and diffusion data from the Human Connectome Project (HCP). Data were downloaded in a minimally pre-processed form and
elaborated using the signal processing technique known as Constrained Spherical Deconvolution (CSD). Regions of interest (ROI) were delineated by means of
multi-atlas automated segmentation: Substantia nigra (SN) and Ventro Tegmental Area (VTA) were resliced into subject space from Adcock’s probabilistic atlas;
dentate nucleus (both dorsal and ventral part) using the deep cerebellar nuclei atlas featured in SPM Anatomy Tract colors are attributed according to the spatial
orientation of streamlines: superior-inferior (blue), anterior-posterior (green), and latero-lateral (red).
FIGURE 6 | Dentate-nigral interconnections. Coronal view shows the
interconnections between the right dentate nucleus and the ipsilateral SN, and
the left dentate nucleus and the ipsilateral SN. The fibers exited the cerebellum
via the right and left superior cerebellar peduncles.
peduncle (SCP; Coenen et al., 2012). These findings have been
replicated in a study by using more advanced signal modeling
algorithms and different tracking strategies (Coenen et al., 2018).
Nevertheless, results coming from diffusion imaging should be
interpreted with care due to the well-known limitations of the
tractographic approach, such as the inability to detect axons
or synapses and, then, to rule out the precise termination of
putative white substance tracts at a cellular level as well as to
distinguish between direct or indirect connectivity patterns and
passing-by fibers (Jbabdi and Johansen-Berg, 2011). In particular,
the inherently low spatial resolution of diffusion-weighted MRI
makes it difficult to distinguish between SNpc, SNpr, and
VTA, as their precise boundaries are not readily identifiable on
conventional MRI scans (Chowdhury et al., 2013; Trutti et al.,
2019). In addition, these results may be affected by passing-by
fibers from the dento-rubro-thalamic tract (DRTT), which lies
in close proximity to midbrain dopaminergic structures, despite
FIGURE 7 | Dentate-VTA interconnections. Coronal view shows the
interconnections between the right dentate nucleus and the ipsilateral and
contralateral VTA, and the left dentate nucleus and the ipsilateral and
contralateral VTA. The fibers exited the cerebellum via the right and left
superior cerebellar peduncles.
a recent study having suggested the potential dissociability of
the cerebellar branch of MFB from DRTT (Hosp et al., 2019). In
addition, in a human brain structural connectivity tractographic
reconstruction of SNpc and VTA, we evidenced the existence of
wide interconnections of the cerebellum with the SNpc and also
with the VTA (Figure 5).
In addition, recently, by means of Constrained Spherical
Deconvolution tractography (CSDt), Milardi et al. (2016) carried
out a detailed analysis of direct links between the ventral and
dorsal dentate nucleus and the ipsilateral SNpc (Figures 6, 8;
Milardi et al., 2016). Subsequently, by means of CSDt, the
existence of direct interconnections between the ventral and
dorsal dentate nucleus and ipsilateral and contralateral VTA,
predominantly characterized by an ipsilateral dentate-VTA links,
has also been demonstrated (Figures 7, 8; Bareš et al., 2015;
Milardi et al., 2016; Cacciola et al., 2017a; Flace et al., 2017,
2018a,b, 2019b, 2020).
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FIGURE 8 | Dentate-SN and dentate-VTA interconnections. Coronal view
shows the interconnections between the right dentate nucleus and left dentate
nucleus to the ipsilateral SN, between the right dentate nucleus and left
dentate nucleus to the ipsilateral and contralateral VTA. The fibers exited the
cerebellum via the right and left superior cerebellar peduncles.
The interconnection studies conducted with invasive methods
in non-humanmammals, and the analyses carried out in humans
by means of tractographic neuroimaging methods highlight the
presence of relevant interconnections of the cerebellum with the
traditional dopaminergic areas of the brain. Moreover, this may
likely suggest double direct functional DA interactions between
the cerebellar dopaminergic system described in this review and
the traditional DA cell groups system of the CNS (Figure 9;
Björklund and Dunnett, 2007). In addition, these cerebellar-
midbrain dopaminergic interconnections could represent part of
the cerebellar projective circuits which allow the cerebellum to
contribute to motor and cognitive functions (Koziol et al., 2014;
Caligiore et al., 2017).
THE ROLE OF THE DOPAMINERGIC
CEREBELLAR SYSTEM IN NEUROLOGIC
AND PSYCHIATRIC DISORDERS
Though several studies suggested an involvement of the
cerebellum in dopaminergic related neurologic and psychiatric
disorders as PD (Jellinger, 1999, 2017; Lewis et al., 2013; Wu and
Hallett, 2013), SCZ (Andreasen and Pierson, 2008; O’Hallaran
et al., 2012; Parker et al., 2014), and ASD (O’Hallaran et al.,
2012; Hampson and Blatt, 2015; Phillips et al., 2015), the precise
role of the cerebellar dopaminergic system has not been fully
characterized yet.
In this review, briefly, we analyzed some considerable
experimental and clinical aspects of the cerebellum related to the
dopaminergic system and its disorders.
Currently, only in few detailed studies has the direct
involvement of a dopaminergic system at the cerebellar level in
PD been analyzed. In a 6-hydroxydopamine (6-OHDA) animal
model, increases in the DA level and its metabolites in the
anterior cerebellum and as well as a decrease in the caudate-
putamen have been detected (Kolasiewicz et al., 2012). In the
cerebellum of PD patients, a reduced mRNA expression of TH
and of some dopaminergic receptor subtypes (DRD1-DRD3) has
been found (Hurley et al., 2003). In a human PD postmortem
brain study it was shown that in the Purkinje neurons, a high
expression of the calpain II (calpastatin), a calcium-dependent
protease, resulted in overexpression in the dopaminergic neurons
of SNpc (Mouatt-Prigent et al., 2000). PTEN-induced putative
kinase 1 (PINK1) mutations related to the recessive genetic
forms of parkinsonism, in the cerebellum of PD patients in
Purkinje neuron and in several neuron types of dentate nuclei
have been detected (Blackinton et al., 2007; Dodson and Guon,
2007).
The deposition of cerebellar α-synuclein (α-S) during PD
remains unclear (Takahashi and Wakabayashi, 2001; Kingsbury
et al., 2004). Indeed, some studies evidenced the presence
of decreased or unchanged levels of α-S in the cerebellum
(Tan et al., 2005; Westerlund et al., 2008), while others
demonstrated a high mRNA expression of the α-S gene
(SNCA) in the human cerebellum (Fuchs et al., 2008).
Moreover, in the cerebellum of PD patients and of [A30P]
transgenic mouse as well as in α-S in the molecular layer,
the Bergmann glia (Mori et al., 2003; Piao et al., 2003), in
the Purkinje neurons, in the space of Held of the granular
layer, in the neuropil and in cell bodies and processes
of different neuron types of the dentate nucleus has been
found (Kahle et al., 2000; Mori et al., 2003). Furthermore,
an α-S neuroprotective activity in cerebellar granules against
neurotoxicity of 6-OHDA has been also demonstrated (Monti
et al., 2007).
In rat cerebellum, high mRNA expression of
clusterin/apolipoprotein J, a glycoprotein involved in the
regulation of α-S deposition (Sasaki et al., 2002; Emamzadeh,
2017) in the Purkinje neurons as well as in the neurons of the
fastigial and interpositus nuclei, has been detected (Pasinetti
et al., 1994).
Currently, no studies are available on the direct involvement
of the cerebellar dopaminergic system in SCZ and in autism
ASD. However, in several studies, the presence of cerebellar
abnormalities in SCZ and ASD patients has been demonstrated.
In SCZ, patterns of atrophy in the cerebellar cortex of the vermis
have been demonstrated (Weinberger et al., 1980; Reyes and
Gordon, 1981; Heath et al., 1982; Snider, 1982; Martin and
Albers, 1995). In addition, reduced cerebellar cortical volumes
(Laidi et al., 2015), a decreased cerebellar gray substance of Crus
I and II ansiform lobules (Kühn et al., 2012), and a reduction
in the gyrification index in the cerebellar vermis have also been
observed (Schmitt et al., 2011). Moreover, in the cerebellum of
SCZ patients, in a microscopical analysis, a loss or a reduced
cell size of the Purkinje neurons has been revealed (Stevens,
1982; Tran et al., 1998). Furthermore, a reduced cerebellar
expression of the Sp transcription factors and DRD2, both related
to negative symptoms of SCZ, has been found (Pinacho et al.,
2013).
In ASD morphological studies, in the cerebellar hemispheres
a reduction of the number of the Purkinje neurons related to a
reduction of the Nissl staining has been demonstrated (Bauman
and Kemper, 1985; Kemper and Bauman, 1993). Furthermore, in
the cerebellum of ASD patients, we also found a reduced Purkinje
neuron density (Whitney et al., 2008; Skefos et al., 2014) together
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FIGURE 9 | The dopaminergic CNS and their interconnections. Cerebellum: Cerebellar Cortex (CC), Deep Cerebellar Nuclei (DCN); Midbrain: Retrorubral Nucleus
(A8), Substantia Nigra Pars Compacta (A9), Ventral Tegmental Area (A10); Hypothalamus (H); Nucleus Accumbens (NAc); Neostriatum (NST); Neocortex (NC). Intrinsic
cerebellar dopaminergic interconnections: Between the dentate nucleus (DN) and the cerebellar cortex (CC); these interconnections are indicated in brown with the
double arrow and the bold line. Extrinsic cerebellar dopaminergic interconnections: Between the dentate nucleus (DN) and the nuclei of the midbrain A8, A9, and A10;
interconnections are indicated in brown with a double arrow and bold line. Between the dentate nucleus (DN) and the Neostriatum (NST); among others Deep
Cerebellar Nuclei Nuclei (DCN) and the NST or the NAc. These interconnections are indicated in brown with the double arrow and the thin dashed line. Other
Dopaminergic Interconnections of the CNS: Interconnection between the Ventral Tegmental Area (A10) and the NAc or between the Ventral Tegmental Area (A10) and
the Neocortex (NC). These interconnections are indicated in brown with the double arrow and the thin dashed line.
with the decreased cell body size of the Purkinje neuron (Fatemi
et al., 2002).
Moreover, studies suggested that SCZ and ASD symptoms, in
part, may be derived from abnormalities of cerebro-cerebellar
interconnections (Andreasen et al., 1998; Strick et al., 2009;
Mosconi et al., 2015).
Furthermore, electrical stimulations of the Purkinje neuron
layer and of the dentate nucleus evokes a long-lasting increase of
DA efflux in the PFC, and this suggests a possible disconnection
between the Purkinje neurons and neuronal population of the
dentate nucleus, which in turn can lead to aberrant DA signaling
in the PFC and to abnormal behavior related to symptoms of SCZ
and ASD (Mittleman et al., 2008; Rogers et al., 2013).
Therefore, the cerebellum and its dopaminergic innervation
and their interconnections to the other midbrain dopaminergic
areas suggested a direct cerebellar involvement in the PD
pathophysiological mechanisms (Lewis et al., 2013; Wu and
Hallett, 2013; Yoo et al., 2019). Furthermore, the relevant role of
the cerebellum is also strongly indicated in psychiatric disorders
such as SCZ and ASD characterized by a significant dysregulation
of the dopaminergic system (Andreasen et al., 1998; Strick et al.,
2009; Mosconi et al., 2015).
THE ROLE OF THE DOPAMINERGIC
CEREBELLAR SYSTEM IN THE
TREATMENT OF NEUROLOGIC AND
PSYCHIATRIC DOPAMINE-RELATED
DISORDERS
Taken together, the data evidenced in the present review,
suggested the existence of a cerebellar dopaminergic neuronal
system, which can be the target for pharmacological, non-
pharmacological, or combined therapeutic treatments (Miterko
et al., 2019); here, we will briefly review some of the therapeutic
aspects on the cerebellar dopaminergic system in PD, SCZ,
and ASD.
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In PD, neuroimaging studies have demonstrated L-DOPA
administration resulted involved in asymmetrical effects inmotor
brain regions, highlighting differences in cerebellar activity
(Martinu et al., 2014). In PD patients, an increased putamen-
cerebellar activity after abstention of L-DOPA administration
has been proven, suggesting a role for the cerebellum in
compensatory mechanisms (Simioni et al., 2015).
In SCZ antipsychotic treatments, the cerebellum may also
represent part of the pharmacologic target. In rat cerebellum, the
atypical antipsychotic blonaserin and the anxiolytic buspirone
engage extensively in dopamine receptor DRD3 (Baba et al.,
2015; Di Ciano et al., 2017); indeed, in the cerebellum an
extensive distribution of the dopamine receptor DRD3 has been
demonstrated (Barili et al., 2000; Kim et al., 2009). Furthermore,
in genomic DNA isolated from the cerebellum, the atypical
antipsychotic agent olanzapine increased methylation of genes
related to the dopaminergic system, such as DRD5, DOPA
decarboxylase (DDC8), and VMAT2 (SCL18A2/VMAT2; Melka
et al., 2013).
The cerebellum is extensively interconnected to the other
brain regions involved in motor, cognitive, and affective
functions (Milardi et al., 2016; Cacciola et al., 2017a, 2019;
Caligiore et al., 2017; Bostan and Strick, 2018; Flace et al.,
2018b). Although, these cerebellar interconnections have not yet
been fully characterized, in studies, it has been demonstrated
that the cerebellum may represent the ideal target of non-
invasive brain stimulation therapies such as electrical or magnetic
stimulations applied in therapies for neurological and psychiatric
disorders (van Dun et al., 2017; Miterko et al., 2019; Quartarone
et al., 2020). In PD patients, bilateral cerebellar repetitive
Transcranial Magnetic Stimulation (rTMS) induced persistent
clinical beneficial effects, reducing peak-dose L-DOPA-induced
dyskinesia (Koch, 2010).
In healthy subjects, cerebellar vermal theta burst stimulation
(TBS) produced downstream changes in neuronal activity in
the frontal cortex (Schutter et al., 2003), and pharmacological
treatment-resistant SCZ patients can improved cognitive
functions (Demirtas-Tatlidede et al., 2010). The rTMS In ASD
has been used to study excitatory/inhibitory imbalance (Uzunova
et al., 2016) and can represent an innovative therapeutic
approach for reducing some of the core and associated ASD
symptoms (Oberman et al., 2016).
DISCUSSION AND CONCLUSION
The present review extensively evidenced the available
morphological, chemical, and functional data on the existence
of a cerebellar dopaminergic system in mammals including
humans, which consist of extrinsic fibers which originate mainly
from the midbrain cerebellar dopaminergic nuclei (A8-A10; Ikai
et al., 1992; Nelson et al., 1997) and of intrinsic dopaminergic
neuronal subpopulations mainly composed of cortico-cerebellar
projective neuron types, such as the Purkinje neuron and the
synarmotic neuron, and by different cerebello-nuclear neuron
types (Nelson et al., 1997; Delis et al., 2008; Flace, 2017; Flace
et al., 2018a, 2019b).
In addition, this review evidenced the presence of direct
dentate-SNpc and dentate-VTA interconnections (Milardi et al.,
2016; Flace et al., 2017, 2018a, 2019b, 2020), which may play a
relevant modulatory role in DA release at the PFC (Mittleman
et al., 2008; Rogers et al., 2013) and highlight the possible
involvement of dopaminergic cerebellar circuits in dopaminergic
related disorders such as PD (Wu and Hallett, 2013; Flace et al.,
2018a, 2019b, 2020), SCZ (Martin and Albers, 1995; Mittleman
et al., 2008; Rogers et al., 2013; Parker et al., 2014), and ASD
(Kemper and Bauman, 1993; Mittleman et al., 2008; Rogers et al.,
2013).
Finally, we suggest that the cerebellar dopaminergic system
and its interconnections may represent an ideal candidate for
innovative non-invasive treatments such as electrical or magnetic
stimulations in neurological and psychiatric disorders (Demirtas-
Tatlidede et al., 2010; Koch, 2010; Oberman et al., 2016; Miterko
et al., 2019; Quartarone et al., 2020). These innovative therapeutic
objectives constitute relevant elements of study and we hope that
they can be achieved in a relatively short time.
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(2010). Morphology and classification of large neurons in the adult human
dentate nucleus a qualitative and quantitative analysis of 2D images. Neurosci.
Res. 67, 1–7. doi: 10.1016/j.neures.2010.01.002
Rogers, T. D., Dickson, P. E., McKimm, E., Heck, D. H., Goldowitz, D., Blaha, C.
D., et al. (2013). Reorganization of circuits underlying cerebellar modulation
of prefrontal cortical dopamine in mouse models of autism spectrum disorder.
Cerebellum 12, 547–556. doi: 10.1007/s12311-013-0462-2
Rosin, D. L., Talley, E. M., Lee, A., Stornetta, R. L., Gaylinn, B. D., Guyenet, P. G.,
et al. (1996). Distribution alpha 2C-adrenergic receptor-like immunoreactivity
in the rat central nervous system. J. Comp. Neurol. 372, 135–165.
doi: 10.1002/(SICI)1096-9861(19960812)372:1andlt;135::AID-CNE9andgt;3.0.
CO;2-4
Roubein, I. F., and Embree, L. J. (1979). Post mortem stability of catecholamines
in discrete regions of rat brain. Res. Commun. Chem. Pathol. Pharmacol.
23, 143–153.
Sachs, C., Jonsson, G., and Fuxe, K. (1973). Mapping of central
noradrenaline pathways with 6-hydroxy-DOPA. Brain Res. 63, 249–261.
doi: 10.1016/0006-8993(73)90092-9
Saitow, F., Murano, M., and Suzuki, H. (2009). Modulatory effects of serotonin
on GABAergic synaptic transmission and membrane properties in the deep
cerebellar nuclei. J. Neurophysiol. 101, 1361–1374. doi: 10.1152/jn.90750.2008
Sanchez-Perez, A., Llansola, M., Cauli, O., and Felipo, V. (2005). Modulation of
NMDA receptors in the cerebellum. II. Signalling pathways and physiological
modulators regulating NMDA receptor function. Cerebellum 4, 162–170.
doi: 10.1080/14734220510008003
Sari, Y., Miquel, M. C., Brisorgueil, M. J., Ruiz, G., Doucet, E., Hamon, M., et al.
(1999). Cellular and subcellular localization of 5-hydroxytryptamine1B
receptors in the rat central nervous system: immunocytochemical,
autoradiographic and lesion studies. Neuroscience 88, 899–915.
doi: 10.1016/S0306-4522(98)00256-5
Sasaki, K., Doh-ura, K., Wakisaka, Y., and Iwaki, T. (2002).
Clusterin/apolipoprotein J is associated with cortical Lewy bodies:
immunohistochemical study in cases with alpha-synucleinopathies. Acta
Neuropathol. 104, 225–230. doi: 10.1007/s00401-002-0546-4
Sastry, B. R., Morishita, W., Yip, S., and Shew, T. (1997). GABA-ergic
transmission in deep cerebellar nuclei. Prog. Neurobiol. 53, 259–271.
doi: 10.1016/S0301-0082(97)00033-6
Schibusawa, N., Hashimoto, K., and Yamada, M. (2008). Thyrotropin-
releasing hormone (TRH) in the cerebellum. Cerebellum 7, 84–95.
doi: 10.1007/s12311-008-0033-0
Schmitt, A., Schulenberg, W., Bernstein, H. G., Steiner, J., Schneider-Axmann,
T., Yeganeh-Doost, P., et al. (2011). Reduction of gyrification index in the
cerebellar vermis in schizophrenia: a post-mortem study. World J. Biol.
Psychiatry 12(Suppl 1), 99–103. doi: 10.3109/15622975.2011.598379
Schoeps, K. O., Halldin, C., Någren, K., Swahn, C. G., Karlsson, P., Hall, H.,
et al. (1993) Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-
11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine
in primates. Nucl. Med. Biol. 20, 669–678. doi: 10.1016/0969-8051(93)90038-v
Schutter, D. J., van Honk, J., d’Alfonso, A. A., Peper, J. S., and Panksepp, J.
(2003). High frequency repetitive transcranial magnetic over the medial
cerebellum induces a shift in the prefrontal electroencephalography
gamma spectrum: a pilot study in humans. Neurosci. Lett. 336, 73–76.
doi: 10.1016/S0304-3940(02)01077-7
Sievers, J., Berry, M., and Baumgarten, H. (1981). The role of noradrenergic fibers
in the control of post-natal cerebellar development. Brain Res. 207, 200–208.
doi: 10.1016/0006-8993(81)90694-6
Sievers, J., and Klemm, H. P. (1982). Locus coeruleus – cerebellum: interaction
during development. Bibl. Anat. 23, 56–75.
Siggins, G. R., Hoffer, B. J., Oliver, A. P., and Bloom, F. E. (1971). Activation
of a central noradrenergic projection to cerebellum. Nature 233, 481–483.
doi: 10.1038/233481a0
Simioni, A. C., Dagher, A., and Fellows,. L. K. (2015). Compensatory striatal-
cerebellar connectivity in mild-moderate Parkinson’s disease.Neuroimage Clin.
10, 54–62. doi: 10.1016/j.nicl.2015.11.005
Skefos, J., Cummings, C., Enzer, K., Holiday, J., Weed, K., and Levy,
E. (2014). Regional alterations in Purkinje cell density in patients
with autism. PLoS ONE 9:e81255. doi: 10.1371/journal.pone.00
81255
Snider, S. R. (1982). Cerebellar pathology in schizophrenia–cause or
consequence? Neurosci. Biobehav. Rev. 6, 47–53. doi: 10.1016/0149-7634(82)
90006-9
Snider, S. R., and Maiti, A. (1976). Cerebellar contributions to the papez circuits J.
Neurosci. Res. 2, 133–146. doi: 10.1002/jnr.490020204
Spokes, E. G. (1979). An analysis of factors influencing measurements
of dopamine, noradrenaline, glutamate decarboxylase and choline
acetylase in human post-mortem brain tissue. Brain 102, 333–346.
doi: 10.1093/brain/102.2.333
Stevens, J. R. (1982). “Neurology and neuropathology of schizophrenia,” in
Schizophrenia and Brain Disease, eds F. A. Henn andH. S. Nasrallah (NewYork,
NY: University Press), 112–147.
Frontiers in Systems Neuroscience | www.frontiersin.org 18 August 2021 | Volume 15 | Article 650614
Flace et al. The Cerebellar Dopaminergic System
Strahlendorf, J. C., Lee, M., and Strahlendorf, H. K. (1984). Effects of serotonin on
cerebellar Purkinje cells are dependent on the baseline firing rate. Exp. Brain
Res. 56, 50–58. doi: 10.1007/BF00237441
Strahlendorf, J. C., Lee, M. H., and Strahlendorf, H. K. (1991). Serotoninmodulates
muscimol- and baclofen-elicited inhibition of cerebellar Purkinje cells. Eur. J.
Pharmacol. 201, 239–242. doi: 10.1016/0014-2999(91)90352-Q
Strick, P. L., Dum, R. P., and Fiez, J. A. (2009). Cerebellum
and nonmotor function. Annu. Rev. Neurosci. 32, 413–434.
doi: 10.1146/annurev.neuro.31.060407.125606
Tabata, T., and Kano, M. (2006). GABA (B) receptor-mediated modulation
of glutamate signalling in cerebellar Purkinje cells. Cerebellum 5, 127–133.
doi: 10.1080/14734220600788911
Takada, M., Sugimoto, T., and Hattori, T. (1993). Tyrosine hydroxylase
immunoreactivity in cerebellar Purkinje cells of the rat. Neurosci. Lett. 150,
61–64. doi: 10.1016/0304-3940(93)90108-W
Takahashi, H., and Wakabayashi, K. (2001). The cellular pathology of Parkinson’s
disease. Neuropathology 21, 315–322. doi: 10.1046/j.1440-1789.2001.00403.x
Takeuchi, Y., Kimura, H., and Sano, Y. (1982). Immunohistochemical
demonstration of the distribution of serotonin neurons in the brainstem
of the rat and cat. Cell. Tissue Res. 224, 247–267. doi: 10.1007/BF00216872
Talley, E. M., Rosin, D. L., Lee, A., Guynet, P. G., and Lynch,
K. R. (1996). Distribution of alpha 2A-adrenergic receptor-like
immunoreactivity in the rat central nervous system. J. Comp. Neurol.
372, 111–134. doi: 10.1002/(SICI)1096-9861(19960812)372:1andlt;111::AID-
CNE8andgt;3.0.CO;2-6
Tan, E. K., Chandran, V. R., Fook-Chong, S., Shen, H., Yew, K., Teoh, M. L., et al.
(2005). Alpha-synuclein mRNA expression in sporadic Parkinson’s disease.
Mov. Disord. 20, 620–623. doi: 10.1002/mds.20391
Törk, I. (1990). Anatomy of the serotonergic system. Ann. N. Y. Acad. Sci. 600,
9–34. doi: 10.1111/j.1749-6632.1990.tb16870.x
Tran, K. D., Smutzer, G. S., Doty, R. L., and Arnold, S. E. (1998). Reduced Purkinje
cell size in the cerebellar vermis of elderly patients with schizophrenia. Am. J.
Psychiatry 155, 1288–1290. doi: 10.1176/ajp.155.9.1288
Trutti, A. C., Mulder, M. J., Hommel, B., and Forstmann, B. U. (2019). Functional
neuroanatomical review of the ventral tegmental area. Neuroimage 191,
258–268. doi: 10.1016/j.neuroimage.2019.01.062
Uusisaari, M., and De Schutter, E. (2011). The mysterious microcircuitry of the
cerebellar nuclei. J. Physiol. 589, 3441–3457. doi: 10.1113/jphysiol.2010.201582
Uzunova, G., Pallanti, S., andHollander, E. (2016). Excitatory/inhibitory imbalance
in autism spectrum disorders: Implications for interventions and therapeutics.
World J. Biol. Psychiatry 17, 174–186. doi: 10.3109/15622975.2015.10
85597
van Dun, K., Bodranghien, F., Manto, M., and Mariën, P. (2017). Targeting the
cerebellum by noninvasive neurostimulation: a review.Cerebellum 16, 695–741.
doi: 10.1007/s12311-016-0840-7
Van Essen, D. C., Smith, S. M., Barch, D. M., Behrens, T. E. J., Yacoub, E., and
Ugurbil, K. (2013). The WU-Minn human connectome project: an overview.
Neuroimage 80, 62–79. doi: 10.1016/j.neuroimage.2013.05.041
Varrone, A., Steiger, C., Schou, M., Takano, A., Finnema, S. J., Guilloteau, D., et al.
(2009). In vitro autoradiography and in vivo evaluation in cynomolgus monkey
of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse. 63,
871–880. doi: 10.1002/syn.20670
Verney, C., Gaspar, P., Febvret, A., and Berger, B. (1988). Transient tyrosine
hydroxylase-like immunoreactive neurons contain somatostatin and
substance P in the developing amygdala and bed nucleus of the stria
terminalis of the rat. Dev. Brain Res. 42, 45–58. doi: 10.1016/0165-3806(88)
90200-3
Versteeg, D. H., Van Der Gugten, J., De Jong, W., and Palkovits, M. (1976).
Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res.
113, 563–574. doi: 10.1016/0006-8993(76)90057-3
Vessotskie, J. M., Kung, M. P., Chumpradit, S., and Kung, H. F. (1997).
Quantitative autoradiographic studies of dopamine D3 receptors in
rat cerebellum using [125I]S(-)5-OH-PIPAT. Brain Res. 778, 89–98.
doi: 10.1016/S0006-8993(97)01014-7
Voogd, J., Gerrits, N. M., and Ruigrok, T. J. (1996). Organization
of the vestibulocerebellum. Ann. N. Y. Acad. Sci. 781, 553–579.
doi: 10.1111/j.1749-6632.1996.tb15728.x
Wang, Y., Strahlendorf, J. C., and Strahlendorf, H. K. (1992). Serotonin
reduces a voltage-dependent transient outward potassium current and
enhances excitability of cerebellar Purkinje cells. Brain Res. 571, 345–349.
doi: 10.1016/0006-8993(92)90675-Y
Weinberger, D. R., Kleinman, J. E., Luchins, D. J., Bigelow, L. B., and Wyatt, R. J.
(1980). Cerebellar pathology in schizophrenia: a controlled postmortem study.
Am. J. Psychiatry 137, 359–361. doi: 10.1176/ajp.137.3.359
Westerlund, M., Belin, A. C., Anvret, A., Håkansson, A., Nissbrandt, H., Lind,
C., et al. (2008). Cerebellar alpha-synuclein levels are decreased in Parkinson’s
disease and do not correlate with SNCA polymorphisms associated with disease
in a Swedish material. FASEB J. 22, 3509–3514. doi: 10.1096/fj.08-110148
White, R. B., and Thomas, M. G. (2012). Moving beyond tyrosine hydroxylase
to define dopaminergic neurons for use in cell replacement therapies
for Parkinson’s disease. CNS Neurol. Disord. Drug Targets 11, 340–349.
doi: 10.2174/187152712800792758
Whitney, E. R., Kemper, T. L., Bauman, M. L., Rosene, D. L., and Blatt,
G. J. (2008). Cerebellar Purkinje cells are reduced in a subpopulation of
autistic brains:a stereological experiment using calbindin-D28k. Cerebellum 7,
406–416. doi: 10.1007/s12311-008-0043-y
Wisden, W., Korpi, E. R., and Bahn, S. (1996). The cerebellum: a model system
for studying GABAA receptor diversity. Neuropharmacology 35, 1139–1160.
doi: 10.1016/S0028-3908(96)00076-7
Woodward, D. J., Moises, H. C., Waterhouse, B. D., Yeh, H. H., and Cheun, J.
E. (1991). The cerebellar norepinephrine system: inhibition, modulation, and
gating. Prog. Brain Res. 88, 331–341. doi: 10.1016/S0079-6123(08)63820-0
Wu, T., and Hallett, M. (2013). The cerebellum in Parkinson’s disease. Brain 136,
696–670. doi: 10.1093/brain/aws360
Wuenschell, C. W., Fisher, R. S., Kaufman, D. L., and Tobin, A. J. (1986). In
situ hybridization to localize mRNA encoding the neurotransmitter synthetic
enzyme glutamate decarboxylase in mouse cerebellum. Proc. Natl. Acad. Sci.
U.S.A. 83, 6193–6197. doi: 10.1073/pnas.83.16.6193
Yagishita, S., Hayashi-Takagi, A., Ellis-Davies, G. C., Urakubo, H., Ishii,
S., and Kasai, H. (2014). A critical time window for dopamine actions
on the structural plasticity of dendritic spines. Science 345, 1616–1620.
doi: 10.1126/science.1255514
Yamamoto, T., Ishikawa, M., and Tanaka, C. (1977). Catecholaminergic terminals
in the developing and adult rat cerebellum. Brain Res. 132, 355–361.
doi: 10.1016/0006-8993(77)90428-0
Yew, D. T., Luo, C. B., Shen,W. Z., Chow, P. H., Zheng, D. R., and Yu,M. C. (1995).
Tyrosine hydroxylase- and dopamine-beta-hydroxylase-positive neurons and
fibres in the developing human cerebellum–an immunohistochemical study.
Neuroscience 65, 453–461. doi: 10.1016/0306-4522(94)00521-6
Yoo, H. S., Choi, Y. H., Chung, S. J., Lee, Y. H., Ye, B. S., Sohn, Y. H., et al.
(2019). Cerebellar connectivity in Parkinson’s disease with levodopa-induced
dyskinesia. Ann. Clin. Transl. Neurol. 6, 2251–2260. doi: 10.1002/acn3.50918
Zhang, C., Zhou, P., and Yuan, T. (2016). The cholinergic system in
the cerebellum: from structure to function. Rev. Neurosci. 27, 769–776.
doi: 10.1515/revneuro-2016-0008
Zhang, N., and Ottersen, O. P. (1993). In search of the identity of the cerebellar
climbing fiber transmitter: immunocytochemical studies in rats. Can. J. Neurol.
Sci. 20(Suppl 3), S36–S42. doi: 10.1017/S0317167100048514
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Flace, Livrea, Basile, Galletta, Bizzoca, Gennarini, Bertino,
Branca, Gulisano, Bianconi, Bramanti and Anastasi. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Systems Neuroscience | www.frontiersin.org 19 August 2021 | Volume 15 | Article 650614
